Scott W. Lowe
Impact in
- Cancer Research top 0.01%
- MicroRNA in disease regulation
- Oncology top 0.01%
- Cancer-related Molecular Pathways
Papers in
- Oncology 142
- Cancer-related Molecular Pathways 96
- Co-authors
- Tyler JacksAthena W. LinGregory J. HannonDavid E. HousmanCarlos Cordon‐CardoJordan S. FridmanH. Earl RuleyElisa de Stanchina
- Journals
- Proceedings of the National Academy of Sciences (30 papers)Nature (28 papers)Cell (23 papers)Genes & Development (22 papers)Blood (22 papers)
- Partner nations
- United StatesGermanyCanada
In The Last Decade
Scott W. Lowe
318 papers receiving 68.5k citations
Hit Papers
Peers
Comparison fields: 5 of 188
- Cancer Research 16.9k
- Oncology 23.0k
- Molecular Biology 50.1k
- Aging 1.1k
- Biotechnology 4.0k
Countries citing papers authored by Scott W. Lowe
This map shows the geographic impact of Scott W. Lowe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott W. Lowe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott W. Lowe more than expected).
Fields of papers citing papers by Scott W. Lowe
This network shows the impact of papers produced by Scott W. Lowe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott W. Lowe. The network helps show where Scott W. Lowe may publish in the future.
Co-authors
The 25 scholars most cited alongside Scott W. Lowe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 4 | |
| 4 | Prophylactic and long-lasting efficacy of senolytic CAR T cells against age-related metabolic dysfunction Hit paper breakdown → | 2024 | 104 |
| 5 | 2023 | 7 | |
| 6 | 2021 | 13 | |
| 7 | 2019 | 59 | |
| 8 | 2018 | 71 | |
| 9 | 2017 | 114 | |
| 10 | 2017 | 35 | |
| 11 | 2016 | 128 | |
| 12 | 2016 | 278 | |
| 13 | 2014 | 93 | |
| 14 | 2012 | 20 | |
| 15 | 2012 | 52 | |
| 16 | 2009 | 81 | |
| 17 | The Regulation of AMPK β1, TSC2, and PTEN Expression by p53: Stress, Cell and Tissue Specificity, and the Role of These Gene Products in Modulating the IGF-1-AKT-mTOR Pathways Hit paper breakdown → | 2007 | 505 |
| 18 | 2006 | 19 | |
| 19 | 2005 | 184 | |
| 20 | 1999 | 4 |
About Scott W. Lowe
Scott W. Lowe is a scholar working on Oncology, Cancer Research, Molecular Biology, Hematology and Biotechnology, having authored 325 papers that have together received 69.6k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (96 papers), Acute Myeloid Leukemia Research (33 papers), RNA Interference and Gene Delivery (32 papers), CRISPR and Genetic Engineering (32 papers), Cell death mechanisms and regulation (32 papers), RNA modifications and cancer (30 papers), Epigenetics and DNA Methylation (29 papers) and Protein Degradation and Inhibitors (29 papers). The work is most often cited by research in Cancer Research (16.9k citations), Oncology (23.0k citations), Molecular Biology (50.1k citations), Aging (1.1k citations) and Biotechnology (4.0k citations). Scott W. Lowe has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Tyler Jacks, Athena W. Lin, Gregory J. Hannon, David E. Housman, Carlos Cordon‐Cardo, Jordan S. Fridman, H. Earl Ruley, Elisa de Stanchina, Edward R. Kastenhuber and Eva Hernando. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature, Cell, Genes & Development and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.